Inecalcitol: Phase II ongoing

Hybrigenics will amend an ongoing, French Phase II trial to evaluate daily 300 or 600 µg doses of oral inecalcitol in combination with Taxotere docetaxel. The study, which has enrolled 18 patients wi...